Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Assertio Therapeutics Inc (ASRT) has shared an announcement.
James L. Tyree, the Chairman of the Compensation Committee at Assertio Holdings, Inc., has opted not to seek reelection at the upcoming Annual Meeting of Stockholders. His decision stems from two points of contention: a disagreement over a potential exception to the Board’s mandatory retirement policy for the current Chair, Peter D. Staple, and the Board’s inaction on his proposal to raise the retirement age from 72 to 75. Tyree has been given the chance to publicly agree or dispute the Company’s account of these events.
For a thorough assessment of ASRT stock, go to TipRanks’ Stock Analysis page.